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Abstract
Chondrogenic differentiation of mesenchymal stem cells (MSCs) is accurately regulated by essential transcription factors
and signaling cascades. However, the precise mechanisms involved in this process still remain to be defined. MicroRNAs
(miRNAs) regulate various biological processes by binding target mRNA to attenuate protein synthesis. To investigate the
mechanisms for miRNAs-mediated regulation of chondrogenic differentiation, we identified that miR-145 was decreased
during transforming growth factor beta 3 (TGF-b3)-induced chondrogenic differentiation of murine MSCs. Subsequently,
dual-luciferase reporter gene assay data demonstrated that miR-145 targets a putative binding site in the 39-UTR of SRY-
related high mobility group-Box gene 9 (Sox9) gene, the key transcription factor for chondrogenesis. In addition, over-
expression of miR-145 decreased expression of Sox9 only at protein levels and miR-145 inhibition significantly elevated Sox9
protein levels. Furthermore, over-expression of miR-145 decreased mRNA levels for three chondrogenic marker genes, type
II collagen (Col2a1), aggrecan (Agc1), cartilage oligomeric matrix protein (COMP), type IX collagen (Col9a2) and type XI
collagen (Col11a1) in C3H10T1/2 cells induced by TGF-b3, whereas anti-miR-145 inhibitor increased the expression of these
chondrogenic marker genes. Thus, our studies demonstrated that miR-145 is a key negative regulator of chondrogenic
differentiation by directly targeting Sox9 at early stage of chondrogenic differentiation.
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Introduction
Bone marrow mesenchymal stem cell (MSCs) possess the
potency of self-renewal[1] and multipotential differentiation, such
as chondrocytes, osteoblasts, adipocytes[2]. Additionally, MSCs
present themselves as a ideal candidate for the regeneration of
cartilage as they possess chondrogenic differentiation potential, are
easily obtained and expanded in vitro[3,4]. As chondrogenic
differentiation rarely occurs spontaneously, the investigation of
precise mechanisms for chondrogenic differentiation will ultimate-
ly contribute to a better understanding of skeletal development
and diseases. Chondrogenic differentiation of MSCs is regulated
by several transcription factors and growth factors, such as SRY-
related high mobility group-Box (Sox) genes and the transforming
growth factor (TGF)-b superfamily, respectively. In chondrogen-
esis, TGF-b stimulation is necessary for chondrogenesis derived
from MSCs[2]. Preferentially, TGF-b1 or TGF-b3 is the most
commonly used growth factor for chondrogenic differentiation.
TGF-b3 enhances the early chondrogenesis of MSCs[5] and
maintains a chondrogenic phenotype[6]. The cross-talk between
TGF-b signal and transcription factors has an important role for
the chondrogenesis of MSCs. For example, TGF-b receptor-
regulated Smad3 and p300 cooperatively activate the Sox9-
dependent transcription to promote the early chondrogenesis[7].
However, the precise mechanisms involved in this process still
remain to be defined. Further studies are required to investigate
the molecular mechanisms involved in the regulation of chondro-
genesis of MSCs in response to the stimulation of TGF-b.
MicroRNAs (miRNAs) are short (21–24 nucleotides) noncoding
RNAs, which are crucial regulators of protein-mediated gene
expression [8]. After transcription, miRNA precursors are cleaved
in the nucleus by Drosha [9], exported to cytoplasm by exportin
[10,11], cleaved by Dicer, and then inserted into an RNA-induced
silencing complex (RISC) [12]. MiRNAs repress target mRNA
expression by binding the miRNAs regulatory elements (MREs)
located in 39-untranslated region (39-UTR) of mRNAs [13].
Abundant evidence suggests that miRNAs play critical roles in
controlling cellular processes such as cell proliferation, apoptosis
and differentiation [14,15]. Particularly, miRNAs participate in
controlling stem cells function and differentiation as evidence by
the Drosha complex partners Loquacious (HIV-1 RNA binding
protein 2), which is required for germ-line stem cell maintenance
[16]. Additionally, Dicer-deficient mouse embryonic stem cells
display severe defects in differentiation [17].
Previously, there were few studies about the mechanisms of
miRNAs regulation in chondrogenic differentiation of MSCs.
MiR-140 is tissue-specific for cartilage during embryonic devel-
opment. It plays an important role in both cartilage development
and homeostasis via regulating its downstream target genes,
histone deacetylase 4 (HDAC4) and Smad3 [18,19,20,21]. Lin et al
found that miR-199* might affect its target gene Smad1 to
regulate chondrogenic differentiation [22]. However, more
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differentiation is needed.
In this study, to determine the roles of miRNAs in chondrogenic
differentiation of MSCs, we focused on characterization of miR-
145 whose expression level was gradually decreased during TGF-
b3-induced chondrogenic differentiation of murine MSCs[23].
Other studies have identified the function of miR-145 involved in
various oncogenic pathways [24,25,26], the differentiation of
embryonic stem (ES) cells [27] and smooth muscle cells (SMCs)
fate decisions [28,29,30]. Here, we show that miR-145 has a
complementary role in suppressing chondrogenic differentiation of
the murine embryonic mesenchymal cell line C3H10T1/2 cells.
Through dual-luciferase reporter gene assay and gain- or loss-of-
function experiments, we demonstrated that miR-145 can target
and suppress the expression of SRY-related high mobility group-
Box gene 9 (Sox9). Sox9 is a master positive regulator of
chondrogenesis and regulation of Sox9 may affect chondrogenic
differentiation of MSCs [31,32,33,34]. Importantly, over-expres-
sion or suppression of miR-145 resulted in inhibiting or promoting
chondrogenic differentiation, respectively. Our results suggest that
miR-145 acts as a key mediator to antagonize early chondrogenic
differentiation via attenuating the effect of transcription factor
Sox9.
Results
MiR-145 is down-regulated during TGF-b3-induced
murine MSCs chondrogenic differentiation
In our previous study, miRNA microarray technology was
applied to detect miRNAs expression profiles of three different
stages during chondrogenic differentiation, including murine
MSCs, chondrogenic induction at 7 d, and 14 d after TGF-b3
treatment[23]. The expression of miR-145 significantly decreased
during chondrogenic differentiation. Subsequently, we performed
bioinformatic analyses to predict the target genes of miR-145 using
Pictar [35] and Targetscan [36]. Noticeably, we found Sox9 was
the potential target gene regulated by miR-145. According to the
primary role of Sox9 in the process of MSCs differentiation into
chondrocytes, we hypothesized that Sox9 may be inhibited by
miR-145, which prevents MSCs from differentiating into chon-
drocytes. Furthermore, down-regulation of miR-145 may act as
positive effect on chondrogenic differentiation. Thus qRT-PCR
assay was performed to validate the expression pattern of miR-145
in this study. The results confirmed that miR-145 gradually
decreased in MSCs, which were induced by TGF-b3 (Figure 1).
MiR-145 targets Sox9 by binding 39-UTR of Sox9 mRNA
MiRNAsinhibitmRNA expressionbybindingtheMREs located
in 39-UTR of target mRNA. The Sox9 39-UTR contains one
putative miR-145 seed site which is bound with imperfect
complementation (Figure 2A). To determine if miR-145 targets
Sox9, we applied the luciferase report gene assay using the pMIR-
REPORT Luciferase reporter. Firstly, we constructed a reporter
vector containing a consensus miR-145-binding site within the 39-
UTR (pMIR-PT, Table 1) as a positive control. After we co-
transfected this reporter plasmid into HEK293 cells with pre-miR-
145 or its control pre-miR, we found that luciferase expression
significantly decreased in the HEK293 cells transfected with pre-
miR-145 (Figure 2B). These data indicate miR-145 can suppress
expression of transcripts containing an exact miR-145-binding site
by our luciferase reporter assay. Next, we created specific reporter
vectors,which containedeithertwocopiesoftheendogenousMREs
found in the Sox9 mRNA 39-UTR (pMIR-MRE, Table 1) or
corresponding two copies of the MREs with a scrambled seed
sequence (pMIR-MUT, Table 1). Previous studies have proven that
such reporter constructed with multiple MREs is an available
method for the identification of miRNAstarget genes [37,38,39,40].
Co-transfection of pre-miR-145 with wild-type pMIR-MRE
resulted in a suppression of luciferase gene expression, but co-
transfection of pre-miR-145 and mutant pMIR-MUT did not
(Figure 2B). Furthermore, the suppression effect occurred in a dose
dependentmanner(Figure 2C).Inadditionwefoundthat anti-miR-
145 could overcome the suppression effect when it was co-
transfected with pMIR-MRE and pre-miR-145. However, the
effect of anti-miR-145 was abolished when pMIR-MUT was used
instead of pMIR-MRE (Figure 2D). Taken together, our data
suggest that miR-145 could target Sox9 by binding the MREs
within the Sox9 mRNA 39-UTR.
MiR-145 inhibits Sox9 expression at early stage of
chondrogenic differentiation
The different degree of complementary between miRNA and its
target mRNA probably determines that miRNA repress target
mRNA through two distinct pathways. MiRNA suppresses mRNA
translation bearing imperfect complementary target sequences and
degrades mRNA bearing perfect complementary target sequenc-
es[41,42,43]. Computational algorithms predicted that miR-145
would bind to the Sox9 39-UTR with imperfect complementation,
s u g g e s t i n gt h a ti tm a yn o tr e s u l ti nS o x 9m R N Ac l e a v a g e .T o
demonstrate whether miR-145 acts as attenuator of Sox9 protein
expression, we transfected C3H10T1/2 mesenchymal stem cells with
either pre-miR-145 or anti-miR-145 for 24 h, and then exposed the
transfected cells to the chondrogenic differentiation medium
primarily consisting of TGF-b3. We firstly performed the non-
transfected control in preliminary experiment for optimizing the
condition of transfection with miRNAs. At the optimal condition of
transfection, there is no significant difference of Sox9 protein
expression between tansfected group and non-transfected control
(Figure S1). As expected for the mechanisms of miRNAs regulation,
measured by western blot assay, Sox9 protein level was notably
Figure 1. Differential expression of miR-145 during chondro-
genic differentiation of murine MSCs. Down-regulated expression
of miR-145 in murine MSCs induced by TGF-b3 was identified by qRT-
PCR at different stage of chondrogenic differentiation (0 d, 7 d, 14 d).
The relative expression level of miR-145 in untreated MSCs (0 d) was set
to one, as control. Three independent cell culture experiments were
done and data was represented as mean6sd. *, p,0.05, when
compared with control.
doi:10.1371/journal.pone.0021679.g001
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the cells of miR-145 suppression at 1 d and 7 d but not at 14 d by
TGF-b3treatment(Figure3A).However,qRT-PCRanalysisshowed
no significant change in Sox9 mRNA level in both transfected cells
(Figure 3B-). Thus, these data demonstrate miR-145 inhibits Sox9
protein expression but not mRNA levels in mesenchymal stem cell
line at early stage of chondrogenic differentiation.
MiR-145 inhibits early chondrogenic differentiation
To explore whether miR-145 has an effect on chondrogenic
differentiation, we transfected either pre-miR-145 or anti-miR-145
into C3H10T1/2 cells. After induction of chondrogenic differentia-
tion by medium containing TGF-b3f o r1da n d7d ,q R T - P C R
analysis of C3H10T1/2 cells transfected with pre-miR-145 showed a
significant decrease in the mRNA expression levels of chondrogenesis
markers including Col2a1, Agc1, COMP , Col9a2 and Col11a1
(Figure 4A). Moreover, alcian blue staining intensity were decreased
following pre-miR-145 treatmentf o r3da n d7d( F i g u r e4 B ) .T h e s e
results reveal that miR-145 over-expression inhibits early chondro-
genic differentiation. Inhibition of endogenous miR-145 expression in
C3H10T1/2 cells by transfection of anti-miR-145, under the same
induction conditions as above, resulted in enhancing chondrogenic
differentiation as shown by a significant increase in chondrogenesis
markers at mRNA level (Figure 5A) and alcian blue staining intensity
(Figure 5B). The results of qRT-PCR and alcian blue staining have
shown that modulation of miR-145 effected the expression of genes
and GAGs related to chondrocyte after induced for 7 d. However, the
same effect did not last for 14 d (Figure 4, 5). Collectively, our data
demonstrate that miR-145 act as a key negative regulator of early
chondrogenic differentiation.
Mir-145 has no influence on mRNA expression of C/EBPb
and C/EBPd
To investigate whether the regulation effect of miR-145
mediated by Sox9 is specific to chondrogenesis, we measured
the mRNA expression level of other Sox9 non cartilage target
genes. Sox9 directly binds to the promoter regions of C/EBPb and
C/EBPd to suppress their promoter activity, preventing adipocyte
differentiation[44]. Our results showed that miR-145 has not
effected the mRNA expression of C/EBPb and C/EBPd after
induction of chondrogenic differentiation (Figure 6). It suggests
that the effect which miR-145 regulate chondrogenic differenti-
ation of MSCs mediated by Sox9 in response to TGF-b3i sa
specific influence on genes associated with chondrogenesis.
Mir-145 has no influence on proliferation of C3H10T1/2
cells
Skelotogenesis is dependent upon proliferation of progenitor
cells that is followed by differentiation. To investigate whether
Figure 2. Mir-145 directly targets Sox9. (A) A schematic shows that
the 59 end of miR-145 contains a sequence complementary to the
specific miRNA binding site within the 39-UTR of Sox9 mRNA. (B) Pre-
miR-145 or its negative control was co-transfected with the specific
pMIR-REPORT construct containing a consensus miR-145-binding site
(pMIR-PT) into HEK293 cells. Pre-miR-145 or its negative control was co-
transfected with pMIR-MRE into HEK293 cells. pMIR-PT acts as a positive
control. (C) HEK293 cells were co-transfected with pMIR-MRE together
with varying amounts of pre-miR-145, as indicated. Statistical compar-
isons were made between multiple groups by ANOVA. (D) Anti-miR-145
or its negative control was co-transfected with either pre-miR-145
together with pMIR-MRE or pre-miR-145 together with pMIR-MUT into
HEK293 cells. pMIR-PT acts as a positive control. All cells (B, C, D) were
harvested at 48 h after transfection, and then luciferase activities were
measured and normalized to the phRL-TK activities. Three independent
transfection experiments were done and data was represented as
mean6sd. *, p,0.05, **, p,0.01, when compared with control.
doi:10.1371/journal.pone.0021679.g002
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expression affects cell proliferation, we assessed the proliferation of
C3H10T1/2 cells by direct cell counting. However, treatment of
C3H10T1/2 cells with either pre-miR-145 or anti-miR-145
inhibitor did not significantly effect the cell proliferation (Figure 7).
Discussion
MiRNAs, as endogenous small molecular regulators of gene
expression, play critical roles in stem cell function [45,46] and
provide new insight into precisely controlling cell fate decisions. In
this study we identified that miR-145 can suppress TGF-b3-
induced chondrogenic differentiation of MSCs by directly
targeting Sox9, the key transcription factor for chondrogenesis,
at the post-transcriptional level. After TGF-b3 treatment, the
decrease in expression of miR-145 allows for the positive effect on
chondrogenesis of Sox9, therefore facilitating chondrogenic
differentiation.
Our microarray and qRT-PCR data demonstrate the gradually
decreased expression of mature miR-145 during TGF-b3-induced
chondrogenic differentiation of murine MSCs. The similar
differential expression patterns of miR-145 had been described
in previous studies. MiR-145 is decreased significantly in BMP-2-
induced C2C12 cells detected by microarray analysis [22].
Additionally, compared with the expression level in human
cartilage chondrocytes, miR-145 is also decreased in dedifferen-
tiation of chondrocytes as validated by microarray and qRT-PCR
analysis [47]. Therefore, with the combination of our microarray
and qRT-PCR data, miR-145 emerged as a candidate with
significant potential to participate in the regulation of chondro-
genic differentiation. Although miR-145 has been known to be
involved in vascular pathogenesis via maintaining the differenti-
ation status of smooth muscle cells (SMCs) and regulation of
embryonic stem (ES) cells self-renewal program [27,48], we have
identified another complementary function to inhibit Sox9-
mediated chondrogenesis.
Using Pictar and Targetscan online software for prediction, we
found several potential target genes of miR-145 closely related
with chondrogenesis, specifically transcription factor Sox9 which is
the primary determinant during the early stages of chondrogen-
esis. Pre-chondrogenic mesenchymal cells with a homozygous
deletion of Sox9 are excluded from aggregated wild-type cells in
mesenchymal condensation and cannot express chondrocyte-
specific matrix genes such as Col2a1, Col9a2, Col11a2, and
Agc1 [49]. Our luciferase reporter analysis showed that both
exogenous miR-145 and anti-miR145 inhibitor regulated expres-
sion of luciferase when miR-145 MREs from Sox9 39-UTR was
fused to the luciferase and the effect lost when the scrambled
MREs sequence was used. Furthermore, the magnitude of
suppression was exhibited in a dose-dependent manner. These
results suggest that miR-145 may regulate Sox9 expression by
binding the MREs within the Sox9 39-UTR and prompt us to
investigate whether miR-145 effects chondrogenesis via targeting
Sox9.
Consistent with the important role of Sox9 in regulating
chondrogenesis, our results indicate that over-expression of miR-
145 via pre-mR-145 precursor resulted in inhibition of
C3H10T1/2 mesenchymal stem cells chondrogenic differentia-
tion, as reflected by a decrease in the expression of Sox9 at the
post-transcriptional level and a decrease in the mRNA expression
of early chondrogenic markers including Col2a1, Col9a2, Col11a1
and Agc1. Accompanied with the decrease of Sox9, COMP that it
expresses predominantly in cartilage and is activated by Sox9
binding its promoter [50], was also reduced significantly. In
contrast, inhibition of miR-145 enhanced chondrogenic differen-
tiation as evidenced by the remarkably increased expression of
Col2a1, Col9a2, Col11a1, Agc1 and COMP mRNAs. Both in
over-expression and suppression of miR-145 experiments, we
found Sox9 differential expressed at the post-transcriptional level
but not at the mRNA level. It reveals that miR-145 repressed Sox9
expression via its binding with imperfect complementation to the
Sox9 mRNA 39-UTR through translational inhibition. Further-
more, mir-145 has no effect on expression of C/EBPb and C/
EBPd at mRNA levels in the chondrogenic differentiation. The
results suggest that miR-145 has a specific influence on genes
associated with chondrogenesis in response to TGF-b3. Taken
together, miR-145 represents a key regulator for suppressing the
chondrogenic phenotype in C3H10T1/2 cells by its ability to
directly target Sox9 and probably be responsive to TGF-b3.
However, we can not find the certain evidence that miR-145
would effect on the terminal differentiation of chondrogenesis by a
long-time effect (for 14 d). It is maybe due to the transient
transfection of miRNAs. On basis of current results, we only
demonstrate miR-145 can regulate chondrogenesis at early stage.
Because the condensation and proliferation of mesenchymal
cells is the initial step of chondrogenesis and skelotogenesis, we
used directly counting cells numbers from micromass pellets to
detect the proliferation of C3H10T1/2 cells which were
transfected with pre-miR-145 or anti-miR-145, respectively.
Unexpectedly, there is no significant difference between pre-
miR-145 or anti-miR-145 treatment pellets and their control
treatment pellets. It suggest that the effect of miR-145 regulating
chondrogenic differentiation depends on Sox9-mediated the
promotion of its target genes associated with cartilage, such as
Col2a1, Agc1 and COMP, etc..
An important feature of miRNAs is that one miRNA can
regulate many target genes owing to the short seed match and
imperfect base-pairing between miRNAs and their targets.
Table 1. Synthesized oligonucleotides sequences for generation of luciferase reporter constructs.
Plasmid Oligonucleotides sequences
pMIR-PT F 59-CTAGTAAGGGATTCCTGGGAAAACTGGACA-39
pMIR-PT R 39-ATTCCCTAAGGACCCTTTTGACCTGTTCGA-59
pMIR-MRE F 59-CTAGTTTGTTGTTGTTGATAACAAACTGGAAAtagctaaTTGTTGTTGTTGATAACAAACTGGAAAA-39
pMIR-MRE R 39-AAACAACAACAACTATTGTTTGACCTTTatcgattAACAACAACAACTATTGTTTGACCTTTTTCGA-59
pMIR-MUT F 59-CTAGTTTGTTGTTGTTGATAACAACAGAATGAtagctaaTTGTTGTTGTTGATAACAACAGAATGAA-39
pMIR-MUT R 39-AAACAACAACAACTATTGTTGTCTTACTatcgattAACAACAACAACTATTGTTGTCTTACTTTCGA-59
The sequences of linker are in lowercase.
doi:10.1371/journal.pone.0021679.t001
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differentiation by suppressing other target genes besides Sox9.
There are a few target genes correlated with chondrogenesis
predicted by combination of Pictar and Targetscan, including
Smad3, type-I activin receptor (ACVR1B also known as ALK4)
and type-II activin receptor (ACVR2A). Smad3 has been
confirmed as a positive mediator of TGF-b-induced chondrogen-
esis [51]. ACVR2A can be bound by activins, which belongs to the
TGF-b superfamily of structurally related signaling proteins,
leading to recruitment and phosphorylation of the ACVR1B.
This complex, containing activins, goes on to recruit the R-Smads,
Smad2 or Smad3 [52] thereby involving the regulation of
chondrogenesis. Thus, miR-145 may regulate chondrogenesis by
repressing not only Sox9 but also other genes.
In conclusion, our studies demonstrate that miR-145 is
decreased during TGF-b3-induced chondrogenic differentiation
of murine MSCs. The attenuation of miR-145 expression
positively regulates its direct target gene Sox9, and results in
promoting chondrogenic differentiation of mesenchymal stem cell
line. Our findings indicate that miR-145 plays a key role in
chondrogenesis and may provide a novel mechanism in miRNA-
mediated regulation of chondrogenic differentiation of MSCs.
Materials and Methods
Cell Culture
Isolation of murine MSCs from bone marrow is previously
described [23,53]. Briefly, mouse tibia and femur marrow cavity
was rinsed by the syringes containing the medium under sterile
conditions, which composed of low glucose DMEM (L-DMEM),
10% fetal bovine serum (FBS, Hyclone), 100 units/ml penicillin
and 100 mg/ml streptomycin (Sigma). The rinsed solution was
filtered through a 70 mm filter mesh and incubated at 37uC with
5% CO2 in a humidified incubator. Culture medium was replaced
after 3 h, and every 8 h repeated this step in the following 72 h.
Thereafter, fresh medium was replaced every 3 d until the cells
reached 90% confluence. Cells were passaged by 0.25% trypsin
(Hyclone) for 2 min at room temperature. The fourth generation
cells were used for the following experiments. The Balb/c mice (six
to eight weeks of age) were obtained from Institute of Animal, the
Third Military Medical University (Chongqing, China). The
Southwest institutional Animal Care and Use Committee at the
Third Military Medical University approved all animal protocols.
C3H10T1/2 mesenchymal stem cells and HEK293 cells (ATCC)
were cultured in DMEM-F12 (Hyclone) containing 10% FBS. The
culture medium was replaced every 2–3 d.
Transfection assay
To demonstrate the functional relevance of miR-145, pre-miR-
145 (a final concentration of 50 nM), anti-miR-145 (a final
concentration of 150 nM) or their negative controls were
transfected, respectively, into C3H10T1/2 cells in 6-well pellets
(10
5 cell per well) with 5 ml siPORT NeoFX transfection agent
(Ambion) following the manufacturer’s instructions. After incuba-
tion for 24 h, the transfected cells were trypsinized and subjected
to the chondrogenic differentiation assay. After indicated time
points, the cells were harvested for mRNA and protein analysis.
Chondrogenic Differentiation Assay
Before chondrogenic differentiation, C3H10T1/2 cells ready
for gain- or loss-of-function analysis, were transfected with pre-
miR-145, anti-miR-145 or their negative controls. MSCs ready for
miR-145 expression analysis were directly induced to chondro-
genic differentiation. After transfection and incubation for 24 h,
high density micromass cultures were treated as previously
described [22]. The cells were trypsinized by 0.25% trypsin and
modulated at a density of 10
7 cells/mL. 10 ml of the suspension
was placed into the center of each well on a 12-well plate
(Corning). After incubation for 2 h at 37uC and 5% CO2, wells
were flooded with 1 mL chondrogenic differentiation medium
(Cyagen).The chondrogenic differentiation medium composed of
dexamethasone, ascorbate, ITS+ Supplement, sodium pyruvate,
proline and TGF-b3 was replaced every 2 d.
Quantitative RT-PCR Analysis
To validate the expression pattern of miR-145, which emerged
in the microarray results, qRT-PCR was performed. U6 acted as
an internal control. Total RNA was used to generate cDNA by
MasterAmp RT-PCR kit (Epicentre) according to manufacturer’s
instructions. The RT-PCR primers are as follows- U6: 59-CG-
CTTCACGAATTTGCGTGTCAT-39; miR-145: 59-GTCGTA-
TCCAGTGCGTGTCGTGGAGTCGGCAATTGCACTGGA-
TACGACAGGGATT-39. The cycle parameters for the RT
reaction were 16uC for 30 min, 42uC for 40 min, and 85uC for
5 min, in a final volume of 20 ml. Subsequently, the synthesized
cDNA was used for real-time quantitative PCR with SYBR Green
(Invitrogen) with the amplification parameters: 95uC for 3 min,
followed by 40 cycles of 95uC for 15 s, 60uC for 20 s, 72uC for
20 s, 78uC for 20 s. The primers of real-time PCR are as follows-
U6 forward: 59-GCTTCGGCAGCACATATACTAAAAT-39,
U6 reverse: 59-CGCTTCACGAATTTGCGTGTCAT-39; miR-
145 forward: 59-GGTCCAGTTTTCCCAGG-39, miR-145 re-
verse: 59-CAGTGCGTGTCGTGGAGT-39.
To determine the expression levels of Sox9, Col2a1, Agc1 and
COMP, total RNA was performed RT-PCR using the Rever Tra
Ace-a -First Strand cDNA Synthesis Kit (Toyobo) followed by
real-time quantitative PCR with SYBR Green. b-actin acted as an
internal control. The cycle parameters for the RT reaction were
42uC for 10 min, 30uC for 20 min, and 99uC for 5 min. Next, a
reaction mixture (Promega) containing the SYBR Green and the
appropriate primers was added to a 0.2 ml MicroAmp (ABI),
together with 2 ml of cDNA template, for a final reaction volume
of 20 ml. The amplification parameters were 94uC for 5 min,
followed by 30 cycles of 94uC for 30 s, 57uC for 30 s, 72uC for
30 s. The primers of real-time PCR are as follows-b-actin forward:
59-GATCTTGATCTTCATGGTGCTAG-39, Col2a1 reverse:
59-TTGTAACCACCTGGGACGATATGG-39; Col2a1 forward:
59-CCCGCCTTCCCATTATTGAC-39, Col2a1 reverse: 59-GG-
GAGGACGGTTGGGTATCA-39; Agc1 forward: 59-CGCC-
ACTTTCATGACCGAGAGAC-39, Agc1 reverse: 59-CCC-
Figure 3. Mir-145 represses the expression of Sox9 at protein level in early stage of chondrogenic differentiation. (A) C3H10T1/2 cells
were transfected with pre-miR-145, anti-miR-145 or their control individually. After induced by TGF-b3 for 24 h, 7 d and 14 d, the cells were harvested
for measurement of Sox9 protein expression using Western blot. b-actin acts as an internal control. Quantitation of the Sox9 protein level was
performed using Quantity One software. The result is shown in the below panels. (B) C3H10T1/2 cells were transfected with pre-miR-145, anti-miR-
145 or their control, and then mRNA level of Sox9 were measured using qRT-PCR at 24h. b-actin acts as an internal control in qRT-PCR analysis. The
relative expression level of Sox9 mRNA in cells transfected with control oligonucleotide was set to one, as control. Three independent experiments
were done and data was represented as mean6sd.
doi:10.1371/journal.pone.0021679.g003
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e21679Figure 4. Over-expression of mir-145 inhibits early chondrogenic differentiation of C3H10T1/2 cells. C3H10T1/2 cells were transfected
with pre-miR-145 or its control respectively. (A) After 24 h, 7 d and 14 d of treatment with TGF-b3, all of cells were lysed and then the expression of
chondrogenic differentiation markers, such as Col2a1, COMP, Agc1, Col9a2 and Col11a1, were measured via qRT-PCR. The relative expression level of
mRNA in cells transfected with control oligonucleotide was set to one, as control. (B) After 3 d, 7 d and 14 d of treatment with TGF-b3, all of pellets
were measured by alcian blue staining. Three independent experiments were done and data was represented as mean6sd. *, p,0.05, when
compared with control.
doi:10.1371/journal.pone.0021679.g004
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e21679Figure 5. Suppression of mir-145 enhances early chondrogenic differentiation of C3H10T1/2 cells. C3H10T1/2 cells were transfected
with anti-miR-145 or its control respectively. (A) After 24 h, 7 d and 14 d of treatment with TGF-b3, all of cells were lysed and then the expression of
chondrogenic differentiation markers, such as Col2a1, COMP, Agc1, Col9a2 and Col11a1, were measured via qRT-PCR. The relative expression level of
mRNA in cells transfected with control oligonucleotide was set to one, as control. (B) After 3 d, 7 d and 14d of treatment with TGF-b3, all of pellets
were measured by alcian blue staining. Three independent cell culture experiments were done and data was represented as mean6sd. *, p,0.05,
when compared with control.
doi:10.1371/journal.pone.0021679.g005
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CGCCTGGGTGTCTTCTGCTTC-39, COMP reverse: 59-CC-
CCCACACACACACCCGTAGC-39; Sox9 forward: 59-GGGG-
GTGAGCTTTGATTAATTC-39, Sox9 reverse: 59-GGGATT-
TAAGGCTCAAGGTGTTT-39; Col9a2 forward: 59- AGGGG-
TTGGGGGAGGGAGAG-39, Col9a2 reverse: 59- GGCATG-
GGTGAGGGGTAGTTGGT-39; Col11a1 forward: 59- GGCC-
AAAGGAGAAACCAGGAAG-39, Col11a1 reverse: 59- GGG-
CAGAGGCAGTCAGGAGCT-39; C/EBPb forward: 59- AG-
GGGGTGGAAGAGAGCTGG-39, C/EBPb reverse: 59- GG-
CCGTGCAGATCAGGGAAG-39; C/EBPd forward: 59- TGG-
ACAAGCTGAGCGACGAGTAC-39, C/EBPd reverse: 59- CG-
CGACAGCTGCTCCACCTTC-39. All real-time quantitative
PCR reactions were performed in the PCR System 7500 (ABI).
Data were analyzed using the 2-ddCt method.
Western Blot Analysis
The cell lysates from micromass cultures of C3H10T1/2 cells
transfected with pre-miR-145 or anti-miR-145 were extracted
with lysis buffer containing 50 mM Tris (pH 7.6), 150 mM NaCl,
1% TritonX-100, 1% deoxycholate, 0.1% SDS, 1 mM PMSF and
0.2% Aprotinin (Sigma). After we measured the protein concen-
tration, the equal protein samples were mixed with 56 sample
buffer (Beyotime) and boiled. The samples were resolved by 10%
SDS-PAGE gel and transferred on PVDF membrane (Millipore)
by using the semi-dry transfer method. After blocking in 10% non-
fat dried milk in TBST for 2 h, the blots were incubated with anti-
Sox9 (Santa Cruz, diluted 1:700) or anti-b-actin antibody (Santa
Cruz, diluted 1:1000) at 4uC overnight. b-actin acted as an
internal control. After washing by TBST, the blots were incubated
with a horseradish peroxidase-conjugated secondary antibody
(Santa Cruz, diluted 1:2000) at room temperature for 1 h. The
blots were visualized by Femto (Pierce) following the manufactur-
er’s instructions.
Generation of Luciferase Reporter Constructs
Target sequences for a consensus miR-145-binding site (PT),
two copies of the endogenous MREs sequence in the Sox9 mRNA
39-UTR (MRE) and corresponding two copies of the MREs with a
scrambled MREs sequence (MUT) were synthesized (Invitrogen)
and cloned into the SpeI/ HindIII site of the pMIR-REPORT
Firefly Luciferase reporter vector (Ambion) using standard DNA
techniques. The correctness of three plasmid DNA constructs,
shown as pMIR-PT, pMIR-MRE and pMIR-MUT, were further
identified by sequencing. All target sequences of inserts are
available in Table 1.
Figure 6. Mir-145 has no influence on mRNA expression of C/EBPb and C/EBPd. C3H10T1/2 cells were transfected with pre-miR145, anti-
miR-145 or its control, respectively. After 24 h of treatment with TGF-b3, all of cells were lysed. The expression of C/EBPb and C/EBPd were measured
via qRT-PCR. The relative expression level of mRNA in cells transfected with control oligonucleotide was set to one, as control. Three independent cell
culture experiments were done and data was represented as mean6sd. *, p,0.05, when compared with control.
doi:10.1371/journal.pone.0021679.g006
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For luciferase activity analysis, HEK293 cells (2610
5 cells per
well) were co-transfected with 125 ng of luciferase reporter
constructs, 25 ng of phRL-TK (Promega) Renilla luciferase
plasmid and 10 pmol of miRNAs with 1 ml Lipofectamine 2000
according to the manufacturer’s instructions (Invitrogen). The
miRNAs transfected into cells were purchased from Ambion,
including pre-miR-145 precursor, anti-miR-145 inhibitor and
their respective negative controls. After incubation for 48 h, we
carried out the luciferase assay using dual-luciferase reporter assay
system (Promega) per the manufacturer’s instructions. Measure-
ments of luminescence were performed on the luminometer
(Glomax 20/20, Promega). In the dose-dependent experiment to
explore the efficiency of miR-145 inhibition, 2.5 pmol, 5 pmol,
10 pmol of pre-miR-145 were used, respectively. Three indepen-
dent experiments were performed, each time in triplicate.
Alcian blue stain
To demonstrate the deposition of cartilage matrix proteogly-
cans, representative cultures were collected at indicated time
points (day 3, day 7 and day 14) of induction and sulfated cartilage
glycosaminoglycans (GAGs) were measured by alcian blue
staining. The pellets for alcian blue staining were routinely fixed
by 4% paraformaldehyde, dehydrated and paraffin imbedded.
5 mm sections were stained by 0.5% alcian blue 8GX (Amresco)
for 20 min.
Cell proliferation assay
Directly counting cells numbers from micromass pellets was
used to detect the proliferation of C3H10T1/2 cells. The
micromass pellets which were treated with either pre-miR-145
or anti-miR-145 inhibitor were induced to chondrocytes for 24 h.
Subsequently, all micromass pellets were trypsinized by 0.25%
trypsin and directly counted using a hemacytometer. All
experiment were done in three independent experiments and
repeated counting in triplicate.
Statistical Analysis
Data are expressed as the mean6SD. Statistical comparisons
were made between two groups with the t-test and between
multiple groups with one-way ANOVA. A value of P,0.05 was
considered significant unless otherwise described.
Supporting Information
Figure S1 Preliminary experiment of the non-transfect-
ed controls. Pre-miR-145 (a final concentration of 50 nM), anti-
miR-145 (a final concentration of 50 nM), their negative controls
and non-transfected controls were transfected into C3H10T1/2
cells in 6-well pellets, respectively. After transfection, cells were
induced to chondrocyte by TGF-b3 for 24 h and then harvested
for measurement of Sox9 protein expression using Western blot. b-
actin acts as an internal control. Quantitation of the Sox9 protein
level was performed using Quantity One software. The result is
shown in the below panels. There is no significant difference of
Sox9 protein expression on cells between tansfected group and
non-transfected control. Three independent experiments were
done and data was represented as mean6sd. *, p,0.05, when
compared with control.
(TIF)
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